Colfax schedules investor meetings for planned separation of ESAB, rename to Enovis

Enovis CORP

Virtual investor meetings held March 14, 2022 for Colfax and ESAB.
Separation to create two independent public companies: Enovis (medical tech) and ESAB (fabrication tech).
Post-separation, Colfax will be renamed Enovis Corporation and continue medical technology business.
Investor presentations furnished as Exhibits 99.1 and 99.2.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.